Skip to main content
Galapagos NV logo

Galapagos NV — Investor Relations & Filings

Ticker · GLPG ISIN · BE0003818359 LEI · 549300QKJ78IY0IOV655 BR Manufacturing
Open in API
Filings indexed 2,865 across all filing types
Latest filing 2018-04-20 Remuneration Information
Country BE Belgium
Listing BR GLPG

About Galapagos NV

https://www.glpg.com/

Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.

Recent filings

Filing Released Lang Actions
Galapagos creates new warrant plan
Remuneration Information Classification · 99% confidence The document announces the creation of new warrant plans for employees and directors, detailing the number of warrants, exercise price, and terms. This action directly relates to changes in the company's capital structure and equity compensation plans. This fits the definition of 'Capital/Financing Update' (CAP), as it involves the issuance of securities (warrants) tied to future share capital changes. Although it involves employee compensation, the primary focus is the creation and terms of the warrants themselves, making CAP more specific than Remuneration (DEF 14A) or Share Issue (SHA), which usually cover actual share issuance or buybacks. Given the nature of creating new equity instruments, CAP is the most appropriate classification.
2018-04-20 English
Warrant-GLPG-UitgifteOphefVoorkeurrecht-Art 596.598-EN.pdf
Share Issue/Capital Change Classification · 99% confidence The document is explicitly titled 'Statutory auditor's report to the board of directors' concerning the 'Issuance of shares with cancellation of the preferential subscription right' under Belgian Company Code articles 596 and 598. This document is a formal report by an auditor (Deloitte) providing assurance on financial information related to a capital structure change (issuance of shares/warrants and cancellation of rights). This fits the description of an Audit Report / Information (AR) better than a general financing update (CAP), as it is the auditor's formal opinion on the underlying transaction documentation, not the announcement of the financing itself. It is a standalone report detailing accounting principles and review results, not a full annual report (10-K) or an earnings release (ER).
2018-04-19 English
Warrant Plan 2018_BoD Report_596-598_D.pdf
Board/Management Information Classification · 95% confidence The document is titled "Bijzonder verslag van de Raad van Bestuur overeenkomstig artikelen 596 en 598 van het Wetboek van Vennootschappen" (Special report of the Board of Directors pursuant to articles 596 and 598 of the Companies Code). It details the justification for proposing the cancellation of pre-emptive rights for existing shareholders in the context of issuing warrants (Warrantplan 2018 and Warrantplan 2018 RMV) to employees, directors, and consultants. This type of detailed report, prepared by the Board of Directors to justify a specific corporate action (like issuing capital instruments without pre-emptive rights) under Belgian corporate law (Wetboek van Vennootschappen), aligns closely with documents concerning corporate governance, management decisions, and capital structure changes. While it discusses capital (CAP), the core function is a formal, legally mandated report from the Board explaining a specific transaction and its impact, which often falls under Management/Board disclosures or specific regulatory filings. Given the detailed legal justification and focus on Board actions regarding warrants and shareholder rights, it is most closely related to Board/Management Information (MANG) or a specific type of legal/governance report. Since it is a formal report from the Board justifying a capital action (warrant issuance/cancellation of pre-emption rights) required by specific articles of the Companies Code, it fits best under Board/Management Information (MANG) as it details the Board's rationale and proposed actions concerning corporate structure and compensation/incentives (warrants). It is not a general Earnings Release (ER), Annual Report (10-K), or a simple Dividend Notice (DIV). It is a specific report detailing management/board decisions regarding capital instruments.
2018-04-19 Dutch
Warrant Plan 2018_BoD Report_596-598_E.pdf
Share Issue/Capital Change Classification · 99% confidence The document is explicitly titled a "Special report of the Board of Directors in accordance with articles 596 and 598 of the Belgian Companies Code" concerning the "Cancellation of the preferential subscription rights of the existing shareholders in the framework of Warrant Plan 2018 and Warrant Plan 2018 RMV." This report details the justification for issuing warrants to employees and directors, analyzes the financial consequences (dilution, equity effect), and lists the specific individuals receiving warrants. This content strongly aligns with corporate governance and capital structure documentation related to employee incentive plans, which often requires specific regulatory reporting in jurisdictions like Belgium. Since it is a detailed report justifying a capital action (warrant issuance/cancellation of rights) and is not a general earnings release (ER), a quarterly report (IR), or a standard annual report (10-K), it fits best under Capital/Financing Update (CAP) as it directly concerns the issuance of securities (warrants) and capital structure changes, or potentially Governance Information (CGR) due to the focus on director compensation/incentives. However, the core subject is the mechanism of capital issuance (warrants) and the cancellation of subscription rights, making CAP the most precise fit among the provided options for a specific financing/capital structure document. Reviewing the definitions: - CAP (Capital/Financing Update): Updates on company fundraising, financing activities, or capital structure changes. This fits perfectly as it details a proposed capital increase via warrants. - CGR (Governance Information): Details internal rules, board structure. While it involves directors, the primary action is financial/capital related. - DEF 14A (Remuneration Information): This is about compensation, but this document is about warrants granted as incentives, which is a capital structure event, not just a disclosure of past compensation. Given the focus on the mechanics of issuing warrants and the associated capital structure impact (dilution, authorized capital usage), CAP is the most appropriate classification.
2018-04-19 English
Warrant-GLPG-UitgifteOphefVoorkeurrecht-Art 596.598-NL.pdf
Capital/Financing Update Classification · 95% confidence The document is a formal report from an independent commissioner (Deloitte) addressed to the Board of Directors of Galapagos NV. The content explicitly references Belgian corporate law articles (Wetboek van vennootschappen, specifically articles 596 and 598) concerning the examination of a special report regarding the issuance of warrants and the lifting of pre-emptive rights. This structure—an external auditor/commissioner providing an opinion on management's proposal related to capital structure changes (warrants for employees/directors)—is characteristic of a formal Audit Report or a specific regulatory opinion supporting a capital action. Since it is a standalone report from an auditor/commissioner detailing findings on financial data related to a specific corporate action (warrant issuance), it aligns best with the 'Audit Report / Information' category (AR), which covers standalone audit reports and applied accounting principles, even though it supports a capital event. It is not the full Annual Report (10-K), an Earnings Release (ER), or a general Investor Presentation (IP).
2018-04-19 Dutch
Warrant Plan 2018_BoD Report_583_E.pdf
Capital/Financing Update Classification · 98% confidence The document is explicitly titled "Special report of the Board of Directors in accordance with article 583 of the Belgian Companies Code" concerning the "Issuance of warrants for the benefit of employees, directors and an independent consultant of the Company and its subsidiaries" under specific Warrant Plans. This document details the proposal, justification, and conditions for issuing warrants, which is a form of capital/financing activity related to employee remuneration. While it involves directors and employees, its primary function is to report on a specific corporate action related to capital structure and compensation, mandated by Belgian corporate law. It is not a standard Annual Report (10-K), an Earnings Release (ER), or a general Audit Report (AR). Since it details a specific financing/remuneration scheme involving capital instruments (warrants), it fits best under Capital/Financing Update (CAP). It is a detailed report/plan, not just a brief announcement of a report (RPA/RNS).
2018-04-19 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.